Issue Information
11 February 2021
Issue Information ‐ Author Checklist
11 February 2021
Cordycepin Ameliorates Nonalcoholic Steatohepatitis by Activation of the AMP‐Activated Protein Kinase Signaling Pathway
Tian Lan, Yang Yu, Jing Zhang, Haonan Li, Qiqing Weng, Shuo Jiang, Song Tian, Tonghao Xu, Sha Hu, Guizhi Yang, Yan Zhang, Weixuan Wang, Lexun Wang, Qing Zhu, Xianglu Rong, Jiao Guo – 11 February 2021
A Machine Learning Approach Enables Quantitative Measurement of Liver Histology and Disease Monitoring in NASH
Amaro Taylor‐Weiner, Harsha Pokkalla, Ling Han, Catherine Jia, Ryan Huss, Chuhan Chung, Hunter Elliott, Benjamin Glass, Kishalve Pethia, Oscar Carrasco‐Zevallos, Chinmay Shukla, Urmila Khettry, Robert Najarian, Ross Taliano, G. Mani Subramanian, Robert P. Myers, Ilan Wapinski, Aditya Khosla, Murray Resnick, Michael C. Montalto, Quentin M. Anstee, Vincent Wai‐Sun Wong, Michael Trauner, Eric J. Lawitz, Stephen A. Harrison, Takeshi Okanoue, Manuel Romero‐Gomez, Zachary Goodman, Rohit Loomba, Andrew H. Beck, Zobair M. Younossi – 10 February 2021
Impact of Inflammatory Bowel Disease and Azathioprine on Long‐Term Outcomes After Liver Transplantation for Primary Sclerosing Cholangitis
Matthew Peverelle, Peter De Cruz, Sarang Paleri, Paul J. Gow – 10 February 2021
Using Medication Level Variability to Predict Posttransplant Risk
Eyal Shemesh – 10 February 2021
Extending the Use of Atezolizumab and Bevacizumab to a Liver Transplant Recipient: Need for a Posttransplant Registry
Najib Ben Khaled, Daniel Roessler, Florian P. Reiter, Max Seidensticker, Markus Guba, Enrico N. De Toni – 10 February 2021
Neutrophil‐to‐Lymphocyte Ratio Predicts High‐Risk Explant Features and Waitlist Survival But Is Not Independently Associated With Recurrence or Survival Following Liver Transplantation for Hepatocellular Carcinoma
Emily Harding‐Theobald, Francis Y.K. Yao, Neil Mehta – 10 February 2021 – We assessed the prognostic significance and the clinical stability of the neutrophil‐to‐lymphocyte ratio (NLR) before liver transplantation (LT) in a large cohort of patients with hepatocellular carcinoma (HCC) from a region with a long waitlist time. A high preoperative NLR ≥5 has been reported to predict poor outcomes following LT for HCC, and the NLR has been incorporated into several prognostic models.
Hexa Histidine–Tagged Recombinant Human Cytoglobin Deactivates Hepatic Stellate Cells and Inhibits Liver Fibrosis by Scavenging Reactive Oxygen Species
Ninh Quoc Dat, Le Thi Thanh Thuy, Vu Ngoc Hieu, Hoang Hai, Dinh Viet Hoang, Nguyen Thi Thanh Hai, Tuong Thi Van Thuy, Tohru Komiya, Krista Rombouts, Minh Phuong Dong, Ngo Vinh Hanh, Truong Huu Hoang, Misako Sato‐Matsubara, Atsuko Daikoku, Chiho Kadono, Daisuke Oikawa, Katsutoshi Yoshizato, Fuminori Tokunaga, Massimo Pinzani, Norifumi Kawada – 10 February 2021
LiverLearning®: 2021 Webinar: Developing a Career in Clinical Research
This live webinar will focus on identifying areas of unmet needs and developing a research career. We will have four presenters share their career experiences. An experienced professional will share her experience on doing clinical research in hepatitis B and thoughts on selecting between research, quality improvement or medical educator.